News

General newsResearch

New head of Cancer Research at Peter Mac

August 16, 2018
We are delighted to announce that Professor Ricky Johnstone has been appointed Executive Director, Cancer Research (EDCR).
Read more
General newsResearch

New insight into genetic drivers of aggressive prostate cancer

August 13, 2018
Scientists at Peter Mac and Cardiff University have identified an important genetic driver of aggressive prostate cancer, which may provide a new target to develop improved treatment.
Read more
General newsMedia releasesPatient & carer stories

Peter Mac signs MoU with VACCHO

August 9, 2018
We are proud to sign an MoU with the Victorian Aboriginal Community Controlled Health Organisation today.
Read more
Featured servicesGeneral newsMedia releasesPatient & carer storiesResearchClinical research & trials

Participants needed to help assess online tool for prostate cancer

August 8, 2018
Men with low risk prostate cancer, and their partners, are needed to take part in a study which is assessing a new online tool designed to help navigate their treatment.
Read more
General newsMedia releases

MESSAGE FROM CHAIR AND CHIEF EXECUTIVE

August 2, 2018
Chief Executive Dale Fisher has announced that she will be leaving Peter MacCallum Cancer Centre to take on a national leadership role as CEO of Silver Chain, a leading home health and aged care provider.
Read more
Professor Michael MacManus
ResearchClinical research & trials

Better disease control with combination therapy in patients with early-stage follicular lymphoma

July 31, 2018
An international clinical trial - led by Peter Mac’s Professor Michael MacManus - has shown that a combination therapy significantly improves long-term disease control for patients with localised, follicular lymphoma compared to radiotherapy alone. Follicular lymphoma is the most common type of low-grade lymphoma and it is a slow progressing disease, making clinical trials difficult to conduct.
Read more
(Left to right) Dr Gabrielle Haeusler, Dr Marliese Alexander, Peter Mac Chief Executive Dale Fisher, Dr Elizabeth Pearson
General newsMedia releasesResearchClinical research & trials

Peter Mac researchers awarded Victorian Cancer Agency grants

July 12, 2018
Four Peter Mac researchers have been named as Victorian Cancer Agency (VCA) Fellowship grant recipients.
Read more
Featured servicesGeneral newsMedia releasesPatient & carer storiesClinical research & trials

SABR is feasible, safe and could delay lifelong hormone therapy for some men with advanced prostate cancer 

June 29, 2018
A Peter Mac clinical trial using a highly advanced, single-dose radiotherapy treatment has halted the spread of prostate cancer in some men, delaying the need for conventional lifelong hormone therapy.
Read more
General newsClinical research & trials

Peter Mac researchers win image of the year

June 27, 2018
A compilation of scans of eight Peter Mac patients, created by Professor Michael Hofman and his research team, has been declared “Image of the Year” by the Society of Nuclear Medicine and Molecular Imaging.
Read more
Professor Sherene Loi, head of the Translational Breast Cancer Genomics Laboratory at Peter Mac
General newsMedia releasesResearchClinical research & trials

New understanding of how the immune system responds to breast cancer

June 26, 2018
Peter Mac scientists have described in unprecedented detail how the immune system responds to breast cancer, identifying a potential new target for immunotherapy treatments.
Read more